CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Te Leiderdrop, Netherlands

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • Robotic Rehabilitation Vs Occupational Therapy Chronic Stroke Upper Limb Rehabilitation

    Phase

    N/A

    Span

    105 weeks

    Sponsor

    University of Florence

    Florence

    Recruiting

  • Validation Study of the Italian Version of the "Assessment of Life Habits 4.0" Scale (LIFE-H) for Measuring Participation in Children With Disabilities Aged 5 to 13 Years

    Phase

    N/A

    Span

    149 weeks

    Sponsor

    Meyer Children's Hospital IRCCS

    Florence

    Recruiting

  • Auto-antibody Dosage from Blood Spots for Diagnosis of Type 1 Diabetes and Celiace Disease

    Phase

    N/A

    Span

    73 weeks

    Sponsor

    Meyer Children's Hospital IRCCS

    Florence

    Recruiting

  • Functional MRI During Resting State in Patients with Eating Disorders

    Phase

    N/A

    Span

    106 weeks

    Sponsor

    Meyer Children's Hospital IRCCS

    Florence

    Recruiting

  • Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.

    The protocol will involve both trans-tibial and trans-femoral amputation subjects, for a total duration of up to 5 sessions. Initially, the fall detection algorithm will be evaluated on trans-femoral and trans-tibial amputees performing the test while wearing their prosthesis. In a second step, the experimentally obtained prognostic markers of fall risk will be studied (i.e., using one or both of the perturbation platforms described below). The markers thus obtained are to be validated by comparison with markers already established in clinical practice or in the literature. Experimental platforms The platforms are composed of a mechanism to simulate and investigate the aid that the prosthetic system can provide in the event of a source of tripping and/or slipping.

    Phase

    N/A

    Span

    73 weeks

    Sponsor

    Fondazione Don Carlo Gnocchi Onlus

    Florence

    Recruiting

    Healthy Volunteers

  • Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.

    Phase

    N/A

    Span

    21 weeks

    Sponsor

    Meyer Children's Hospital IRCCS

    Florence

    Recruiting

  • Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis

    Phase

    N/A

    Span

    49 weeks

    Sponsor

    Meyer Children's Hospital IRCCS

    Florence

    Recruiting

  • Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.

    Phase

    N/A

    Span

    93 weeks

    Sponsor

    Meyer Children's Hospital IRCCS

    Florence

    Recruiting

    Healthy Volunteers

  • Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants

    Phase

    N/A

    Span

    313 weeks

    Sponsor

    University of L'Aquila

    Florence

    Recruiting

  • Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

    By retrieving data from several epidemiological and clinical registries across Europe it is aimed to integrate and maximize efforts in order to create a large dataset that serves for a comprehensive analysis of genetic and environmental factors influencing the etiology of melanoma in CAYA. The data will be combined with exposome information about climate and pollution for the development of a weighted risk score. Furthermore, germline high risk mutations and germline low-medium risk variants will be analyzed. Genome and transcriptome sequencing of blood and in selected cases tumour will provide the most comprehensive data to create a polygenic risk score for CAYA melanoma. Transcriptome data will help to identify and characterize the effect of variants of unknown significance in coding, intronic as well as regulatory regions. Tumour sequencing can provide additional information on functional relevance of variants, e.g. secondary hits in tumour tissue or second hits in tumour suppressor genes. Such identification will be highly advantageous to design prevention strategies for melanoma development in CAYA.

    Phase

    N/A

    Span

    126 weeks

    Sponsor

    University Hospital Tuebingen

    Florence

    Recruiting

1-10 of 138
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 609.945.0101

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information